NDC Package 10702-102-01 Methylphenidate Hydrochloride

Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information
Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

10702-102-01

Package Description:

100 TABLET in 1 BOTTLE

Product Code:

10702-102

Proprietary Name:

Methylphenidate Hydrochloride

Non-Proprietary Name:

Methylphenidate Hydrochloride

Substance Name:

Methylphenidate Hydrochloride

Usage Information:

Attention Deficit Disorders, NarcolepsyAttention Deficit Disorders (previously known as Minimal Brain Dysfunction in Children). Other terms being used to describe the behavioral syndrome below include: Hyperkinetic Child Syndrome, Minimal Brain Damage, Minimal Cerebral Dysfunction, Minor Cerebral Dysfunction. Methylphenidate hydrochloride is indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. The diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin. Nonlocalizing (soft) neurological signs, learning disability, and abnormal EEG may or may not be present, and a diagnosis of central nervous system dysfunction may or may not be warranted.Special Diagnostic ConsiderationsSpecific etiology of this syndrome is unknown, and there is no single diagnostic test. Adequate diagnosis requires the use not only of medical but of special psychological, educational, and social resources.Characteristics commonly reported include: chronic history of short attention span, distractibility, emotional lability, impulsivity, and moderate-to-severe hyperactivity; minor neurological signs and abnormal EEG. Learning may or may not be impaired. The diagnosis must be based upon a complete history and evaluation of the child and not solely on the presence of 1 or more of these characteristics.Drug treatment is not indicated for all children with this syndrome. Stimulants are not intended for use in the child who exhibits symptoms secondary to environmental factors and/or primary psychiatric disorders, including psychosis. Appropriate educational placement is essential and psychosocial intervention is generally necessary. When remedial measures alone are insufficient, the decision to prescribe stimulant medication will depend upon the physician’s assessment of the chronicity and severity of the child’s symptoms.

11-Digit NDC Billing Format:

10702010201

Billing Unit:

EA - Billing unit of "each" is used when the product is dispensed in discreet units.

NDC to RxNorm Crosswalk:

100 EA

NDC to RxNorm Crosswalk:

RxCUI: 1091150 - methylphenidate HCl 10 MG Oral Tablet

RxCUI: 1091150 - methylphenidate hydrochloride 10 MG Oral Tablet

RxCUI: 1091392 - methylphenidate HCl 20 MG Oral Tablet

RxCUI: 1091392 - methylphenidate hydrochloride 20 MG Oral Tablet

RxCUI: 1091497 - methylphenidate HCl 5 MG Oral Tablet

Product Type:

Human Prescription Drug

Labeler Name:

Kvk-tech, Inc.

Dosage Form:

Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.

Administration Route(s):

Oral - Administration to or by way of the mouth.

Active Ingredient(s):

METHYLPHENIDATE HYDROCHLORIDE 20 mg/1

Pharmacologic Class(es):

Central Nervous System Stimulant - [EPC] (Established Pharmacologic Class)

Central Nervous System Stimulation - [PE] (Physiologic Effect)

DEA Schedule:

Schedule II (CII) Substances

Sample Package:

FDA Application Number:

ANDA206932

Marketing Category:

ANDA - A product marketed under an approved Abbreviated New Drug Application.

Start Marketing Date:

05-11-2017

Listing Expiration Date:

12-31-2025

Exclude Flag:

Code Structure:

10702 - Kvk-tech, Inc.
- 10702-102 - Methylphenidate Hydrochloride
  - 10702-102-01 - 100 TABLET in 1 BOTTLE

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 10702-102-01?

The NDC Packaged Code 10702-102-01 is assigned to a package of 100 tablet in 1 bottle of Methylphenidate Hydrochloride, a human prescription drug labeled by Kvk-tech, Inc.. The product's dosage form is tablet and is administered via oral form.

Is NDC 10702-102 included in the NDC Directory?

Yes, Methylphenidate Hydrochloride with product code 10702-102 is active and included in the NDC Directory. The product was first marketed by Kvk-tech, Inc. on May 11, 2017 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 10702-102-01?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 100.

What is the 11-digit format for NDC 10702-102-01?

The 11-digit format is 10702010201. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	10702-102-01	5-4-2	10702-0102-01

Table of Contents